2017 Award of Innovation Nominations

Innovation Place and Innovation Enterprise announce this year's nominations

Innovation Place and Innovation Enterprise (Industry Liaison Office) at the University of Saskatchewan announce four outstanding nominations for the Award of Innovation for the 2017 SABEX Awards. The winner of the award will be announced on February 9th at Prairieland Park and will receive a $5,000 cash prize. The Award of Innovation recognizes University of Saskatchewan researchers who have developed innovations, which have great potential for commercial impact.


The following Researchers have been nominated:

Dr. David M. Klymyshyn, a Professor and Graduate Chair in the Department of Electrical and Computer Engineering, has been nominated for the innovation of Polymer Resonator Antennas. Dr. Klymyshyn and his team invented a radically different approach to fabrication of compact radio frequency (RF) antennas and devices using non-traditional polymer-based materials, enabling improved performance and increased functionality for various emerging wireless communication and sensor devices.

Dr. Changiz Taghibiglou, a faculty member in the Department of Pharmacology, has been nominated for two innovations. 1) Dr. Taghibiglou identified two novel and reliable blood-based biomarkers for traumatic brain injury. 2) He also invented a new non—toxic, topical acne treatment where the active ingredients are patented peptides designed to reduce the production of fatty acids and cholesterol by sebocytes.

Dr. Stephen Foley, an Associate Professor in the Department of Chemistry, Hiwa Salimi and Loghman Moradi, PhD students in the Department of Chemistry, have been nominated for developing a new process for selectively removing gold from electronic waste such as printed circuit boards. It is the fastest method known for leaching gold into solution, but in addition to this it is selective for gold, requires no energy input and the reagents used are cheap, recyclable and environmentally benign.

Dr. John Gordon, a Professor in the Department of Medicine, has been nominated for his work in developing a therapeutic approach by which asthma or food allergies have been fully reversed in animal models. Dr. Gordon’s team recently recognized that a complex array of effector molecules, cell types and specialized cell products within the immune system, can be manipulated outside the body and then returned to the body as a treatment.

For more information, contact:

Johannes Dyring
Managing Director Industry Liaison Office
(306) 966-7829

Van Isman
President and CEO Innovation Place
(306) 933-6258 (Saskatoon)
(306) 787-8554 (Regina)

Share this story